Table: Kyorin Pharmaceutical - 6-MTH group results

Kyorin Pharmaceutical

08/11/2023 06:00

Nov 8 (Reuters)- 
             Kyorin Pharmaceutical Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Sep 30, 2023        Sep 30, 2022     Mar 31, 2024 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             54.94               49.09           116.20    
                 (+11.9 pct)         (+0.0 pct)       (+2.6 pct)  
  Operating          1.14              777 mln            6.00    
                 (+47.2 pct)                          (+17.1 pct) 
  Recurring          1.39                1.17             6.50    
                 (+18.4 pct)        (+309.8 pct)      (+11.5 pct) 
  Net                1.76                1.24             4.90    
                 (+41.4 pct)        (+921.1 pct)      (+3.7 pct)  
  EPS             30.66 yen           21.69 yen        85.51 yen  
  Ann Div                             52.00 yen        52.00 yen  
  -Q2 div         20.00 yen           20.00 yen                   
  -Q4 div                             32.00 yen        32.00 yen  
  
  NOTE - Kyorin Pharmaceutical Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4569.T